Drugs Made In America Acquisition Corp. (DMAAR) Total Debt (2024 - 2026)

Drugs Made In America Acquisition (DMAAR) has reported Total Debt for 3 consecutive years, with $350000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Debt changed N/A year-over-year to $350000.0; the trailing twelve-month figure through Jun 2026 stood at $350000.0 (changed N/A YoY), and the FY2024 full-year result was $1.3 million, changed N/A from the prior year.
• Total Debt rose to $350000.0 in Q2 2026 per DMAAR's latest filing, from $121796.0 in the prior quarter.
• Across five years, Total Debt topped out at $1.3 million in Q4 2024 and bottomed at $121796.0 in Q1 2025.
• Historically, Total Debt has averaged $598814.7 across 3 years, with a median of $350000.0 in 2026.